ulbi20181001_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of the earliest event reported)

October 2, 2018

 

 

ULTRALIFE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Delaware

000-20852

16-1387013

(State of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

2000 Technology Parkway, Newark, New York

14513

(Address of principal executive offices)

(Zip Code)

 

(315) 332-7100

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company  [ ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

 

 

 
 

 

Item 8.01 Other Events

 

In a press release dated October 2, 2018, Ultralife Corporation (NASDAQ: ULBI) announced that it has been awarded a contract valued at approximately $10.9 million to supply Vehicle Amplifier-Adaptors (“VAA’s”) and Mounted Power Amplifiers to Thales Defense & Security, Inc., a global leader in the development, manufacture, and support of combat-proven, software-defined radio equipment.  The VAA system supports the U. S. Army’s Network Modernization initiatives, and when integrated with a specific, advanced handheld radio, provides the soldier with an enhanced range of digital voice and data communications and operational flexibility.   Shipments are planned to commence before the end of 2018 and continue throughout 2019. 

 

 

Item 9.01     Financial Statements, Pro Forma Financials and Exhibits

 

(d) Exhibits

 

Exhibit

Number 

   Description
     
99.1    Press Release of Ultralife Corporation dated October 2, 2018

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ULTRALIFE CORPORATION

 

 

October 2, 2018

By:

/s/ Philip A. Fain

 

 

Chief Financial Officer and Treasurer